Notices of Compliance, 2024
2,165 notices issued in 2024, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 31, 2024 | FLORINEF | Endo Operations Ltd. | New Drug Submission (NDS) · Labelling Only |
| December 31, 2024 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM; CLOTRIMAZOLE EXTERNAL CREAM; CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM; CLOTRIMAZOLE VAGINAL 3; CLOTRIMAZOLE VAGINAL 6 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2024 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2024 | AURO-FAMOTIDINE MINT 20 MG | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2024 | LUPIN-CEPHALEXIN | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2024 | MYLAN-ESCITALOPRAM | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2024 | BRUKINSA | Beigene Switzerland Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2024 | OTULFI; OTULFI I.V. | Fresenius Kabi Canada Ltd | New Drug Submission (NDS) · Other |
| December 30, 2024 | BAMBEVI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2024 | BACLOFEN INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2024 | LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 27, 2024 | SANDOZ TRAVOPROST | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 27, 2024 | RIVA-FINASTERIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 27, 2024 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2024 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2024 | LYSODREN | Hra Pharma Rare Diseases | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2024 | AG-DULOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 27, 2024 | JAMP ANASTROZOLE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2024 | SUBLOCADE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2024 | BISOPROLOL TABLETS | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| December 24, 2024 | TRULANCE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 24, 2024 | JAMP DEFERASIROX (TYPE J) | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2024 | APO-DAPAGLIFLOZIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 23, 2024 | ARIMIDEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2024 | MAR-GABAPENTIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2024 | VABOMERE | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Priority-NAS |
| December 20, 2024 | CEFAZOLIN FOR INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | BREYANZI | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2024 | TEVA-CYCLOBENZAPRINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2024 | CEREBYX | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2024 | TEVA-TERBINAFINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | JAMP ROSUVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | PREGABALIN | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | TARO-AMPHOTERICIN B LIPOSOMAL | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 20, 2024 | SANDOZ DAPAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | NEXTSTELLIS | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2024 | NAT-ZOLMITRIPTAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | TARO-ANASTROZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2024 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2024 | TERBINAFINE-250 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2024 | DESVENLAFAXINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2024 | XYLOCARD | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2024 | HUVAMOX | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| December 18, 2024 | POTELIGEO | Kyowa Kirin, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2024 | ADVIL EXTRA STRENGTH LIQUI-GELS; ADVIL LIQUI-GELS; ADVIL ARTHRITIS PAIN | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2024 | STRENSIQ | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2024 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2024 | SANDOZ PREGABALIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2024 | PMS-FLUCONAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2024 | MINT-ZOLMITRIPTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2024 | RINGZA | Duchesnay Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 18, 2024 | PRO-RIVAROXABAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 17, 2024 | JAMP VORICONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 17, 2024 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | RYALTRIS | Glenmark Specialty Sa | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | BIAXIN; BIAXIN BID | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | NUVARING | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | JAMP PERINDOPRIL/INDAPAMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 17, 2024 | SATIVEX | Jazz Pharmaceuticals Operations Uk Limited | New Drug Submission (NDS) · Admin |
| December 17, 2024 | CABAZITAXEL FOR INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 17, 2024 | IODIXANOL INJECTION 270; IODIXANOL INJECTION 320 | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 17, 2024 | CAYSTON | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2024 | M-AMBRISENTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 16, 2024 | WELLBUTRIN XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2024 | PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2024 | VIVOTIF | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | LUTATHERA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | PEXEGRA | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| December 13, 2024 | COLUMVI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | VABYSMO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | VYLOY | Astellas Pharma Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 13, 2024 | NOVAMOXIN; NOVAMOXIN (SUGAR REDUCED) | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2024 | MINT-SITAGLIPTIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 13, 2024 | MINT-AMOXI/CLAV | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2024 | TARO-TOFACITINIB XR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2024 | ESTALIS 140/50 MCG; ESTALIS 250/50 MCG | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2024 | LOKELMA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2024 | COMBOGESIC | BioSyent Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2024 | ACCEL-LEFLUNOMIDE | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2024 | MARCAINE E | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | CARBOPROST TROMETHAMINE INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2024 | MYOZYME | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | AURO-ZOLMITRIPTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2024 | XEOMIN | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | ONIVYDE | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | TARO-DOMPERIDONE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 11, 2024 | SPIKEVAX | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | CHILDREN'S IBUPROFEN SUSPENSION | Perrigo International, Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2024 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2024 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 10, 2024 | BIO-PERINDOPRIL | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 10, 2024 | DELSTRIGO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2024 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2024 | EXTRA STRENGTH ALLERGY RELIEF; REGULAR STRENGTH ALLERGY RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2024 | PIFELTRO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2024 | PMS-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2024 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2024 | ONDANSETRON ODT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2024 | QUETIAPINE XR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2024 | LATANOPROST / TIMOLOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 9, 2024 | CYRAMZA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2024 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2024 | EVRA | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2024 | JAMP IBUPROFEN SUSPENSION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 6, 2024 | OMLYCLO | Celltrion Inc. | New Drug Submission (NDS) · Other |
| December 6, 2024 | RIVA-PREGABALIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2024 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2024 | JAMP-DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2024 | WELLBUTRIN SR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | FLUZONE HIGH-DOSE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | FLUZONE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | FUROSEMIDE SPECIAL INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2024 | BIO-MONTELUKAST | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2024 | BIO-FLUOXETINE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2024 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | DONEPEZIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2024 | ARICEPT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | VINBLASTINE SULFATE INJECTION | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | CLINDAMYCIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 5, 2024 | PRAVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 5, 2024 | SANDOZ AMOXICILLIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2024 | PMS-LETROZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2024 | GENVOYA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2024 | LUPIN-TIOTROPIUM | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2024 | SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2024 | NORVASC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2024 | MED-VORICONAZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2024 | ATORVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 4, 2024 | ESCITALOPRAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2024 | TEVA-DEXTROAMPHETAMINE SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2024 | OLANZAPINE; OLANZAPINE ODT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2024 | JAMP METHOTREXATE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 3, 2024 | AREPANRIX H5N1 | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2024 | FLUCELVAX | Seqirus Uk Limited | New Drug Submission (NDS) · Other |
| December 3, 2024 | M-M-R II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2024 | M-FLUCONAZOLE-150 | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 3, 2024 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2024 | PREGABALIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 3, 2024 | SOHONOS | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2024 | XULTOPHY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2024 | JUBBONTI | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2024 | WYOST | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2024 | JAMP DUTASTERIDE CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2024 | VEOZAH | Astellas Pharma Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 29, 2024 | PIXXOSCAN | Ge Healthcare Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 29, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2024 | AG-ANASTROZOLE TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 29, 2024 | NORTRIPTYLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2024 | BACLOFEN INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 28, 2024 | NB-APIXABAN | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 28, 2024 | TWYNSTA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2024 | MICARDIS PLUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2024 | PMS-TOFACITINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2024 | MINT-BISOPROLOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2024 | SILDENAFIL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2024 | SANDOZ FESOTERODINE FUMARATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2024 | ONDANSETRON | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2024 | JAMP-DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2024 | PMS-LAMOTRIGINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2024 | JAMP DILTIAZEM CD | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2024 | LAMOTRIGINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2024 | MINT-CARBAMAZEPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2024 | AG-LAMOTRIGINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 27, 2024 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| November 27, 2024 | FLUDEOXYGLUCOSE (18F) INJECTION | Shared Health | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 27, 2024 | PMS-CYTARABINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 27, 2024 | JAMP OSELTAMIVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2024 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2024 | TEVA-CLINDAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 26, 2024 | MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP | B.Braun Medical Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2024 | M-LATANOPROST-TIMOLOL | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 26, 2024 | VALACYCLOVIR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 25, 2024 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2024 | GALAFOLD | Amicus Therapeutics Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2024 | EDURANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2024 | DESCOVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2024 | DULOXETINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 22, 2024 | SANDOZ ZOLMITRIPTAN; SANDOZ ZOLMITRIPTAN ODT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2024 | JAMP-MOXIFLOXACIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2024 | TIMOLOL MALEATE OPHTHALMIC SOLUTION | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2024 | ACH-FESOTERODINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2024 | FLUANXOL DEPOT | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2024 | CLOPIXOL ACUPHASE; CLOPIXOL DEPOT | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2024 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2024 | ANTIROBE | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2024 | VAXCHORA | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2024 | OCTAPLEX | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2024 | MEN'S GLN-MINOXIDIL | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2024 | JAMP RIVAROXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2024 | GEMCITABINE INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2024 | CABAZITAXEL FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 20, 2024 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2024 | SOHONOS | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2024 | SANDOZ VALSARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 20, 2024 | CYESTRA-35 | Endo Operations Ltd. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 20, 2024 | JAMP ARIPIPRAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 20, 2024 | BIO-LETROZOLE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| November 20, 2024 | VYNDAMAX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2024 | MARVELON 21; MARVELON 28 | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2024 | PYCEZE | Intervet Canada Corp | New Drug Submission (NDS) · Admin |
| November 19, 2024 | LISINOPRIL/HCTZ (TYPE Z) | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 19, 2024 | SEVOFLURANE | Blue-Zone Technologies Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| November 19, 2024 | VANIQA | Cipher Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2024 | TARO-DONEPEZIL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 18, 2024 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2024 | VISTASEAL | Instituto Grifols S.A. | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2024 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2024 | PRO-SITAGLIPTIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2024 | ETOPOSIDE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2024 | FUROSEMIDE INJECTION USP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS; ADVIL COLD & SINUS LIQUI-GELS; ADVIL COLD AND SINUS; ADVIL COLD AND SINUS DAYTIME; CHILDREN'S ADVIL COLD | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | APO-DOXYLAMINE/B6 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | VORICONAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | TARO-CLINDAMYCIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | SILDENAFIL | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2024 | LOSARTAN HCT; LOSARTAN HCT DS | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2024 | PLAN B | Foundation Consumer Healthcare, Llc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | NRA-CLINDAMYCIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2024 | MYLAN-LATANOPROST | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| November 15, 2024 | DILTIAZEM CD | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2024 | DIARRHEA RELIEF LIQUID GELS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 15, 2024 | CIBINQO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | NUVARING | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | PRAMIPEXOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2024 | SANDOZ VALSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | METHOTREXATE INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | EUGIA-PAZOPANIB | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2024 | MYLAN-ONDANSETRON | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2024 | CRESEMBA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | BLEXTEN | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | GAVRETO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2024 | IPG-QUETIAPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2024 | TEVA-OMEPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 13, 2024 | WILATE | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| November 13, 2024 | JAMTEKI; JAMTEKI IV | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 13, 2024 | WEZLANA I.V.; WEZLANA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 13, 2024 | STRAMUCIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 13, 2024 | JORNAY PM | Ironshore Pharmaceuticals & Development Inc | New Drug Submission (NDS) · Other |
| November 13, 2024 | MICRO+6 REGULAR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 13, 2024 | TARO-DEFERIPRONE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 12, 2024 | MIDAZOLAM INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 12, 2024 | MAR-EZETIMIBE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 12, 2024 | JULUCA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | NOLVADEX - D | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | TRIUMEQ | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2024 | IFEX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | ALYSENA 21; ALYSENA 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2024 | ELTROXIN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2024 | NAT-SUNITINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | CARVYKTI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2024 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2024 | TEVA-TICAGRELOR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | APO-VENLAFAXINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2024 | AG-FLUOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2024 | OJJAARA | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 8, 2024 | LEVOTHYROXINE SODIUM FOR INJECTION; LEVOTHYROXINE SODIUM INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2024 | TEVA-TICAGRELOR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | TEVA-PRAZOSIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2024 | TEVA-AMLODIPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | MYLAN-GALANTAMINE ER | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | TARO-FAMPRIDINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | AURO-VALACYCLOVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2024 | NRA-HYDROXYCHLOROQUINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2024 | QUVIVIQ | Idorsia Pharmaceuticals Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2024 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 7, 2024 | FINLIUS; FINLIUS I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 7, 2024 | LETYBO | Hugel Canada Inc. | New Drug Submission (NDS) · Admin |
| November 7, 2024 | RIVA-AMIODARONE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2024 | MRESVIA | Moderna Biopharma Canada Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 6, 2024 | TAVNEOS | Vifor Fresenius Medical Care Renal Pharma Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2024 | DOVATO | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2024 | CETROTIDE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2024 | DEXEDRINE; DEXEDRINE SPANSULE | Endo Operations Ltd. | New Drug Submission (NDS) · Labelling Only |
| November 6, 2024 | PRO-SITAGLIPTIN-METFORMIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2024 | AMLODIPINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2024 | KYE-ESCITALOPRAM | Kye Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 5, 2024 | TECVAYLI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2024 | RABAVERT | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2024 | MAVIRET | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2024 | WIXELA INHUB | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 5, 2024 | KETAMINE INJECTION, BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2024 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2024 | REVOLUTION PLUS | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2024 | FAMPYRA | Merz Therapeutics Gmbh | New Drug Submission (NDS) · Admin |
| November 1, 2024 | DRAXIMAGE GLUCEPTATE | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2024 | BIJUVA | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2024 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2024 | AREXVY | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2024 | AG-DESVENLAFAXINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 1, 2024 | DOMPERIDONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 1, 2024 | LIVTENCITY | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2024 | LISINOPRIL (TYPE Z) | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 1, 2024 | DYMISTA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2024 | REDDY-RIVAROXABAN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2024 | SEPTRA INJECTION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2024 | BIKTARVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2024 | SUNLENCA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2024 | SUMMIT ULTRA | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2024 | PERIDEX ORAL RINSE | 3M Healthcare Canada Company Limited | New Drug Submission (NDS) · Admin |
| October 30, 2024 | ACCEL-ONDANSETRON ODT | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2024 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2024 | ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2024 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2024 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2024 | EXTRA STRENGTH TYLENOL NIGHTTIME | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2024 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2024 | PROLASTIN-C; PROLASTIN-C LIQUID | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2024 | AG-ROSUVASTATIN CALCIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 29, 2024 | AG-BISOPROLOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 29, 2024 | DUTASTERIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 29, 2024 | FAMPYRA | Acorda Therapeutics Ireland Ltd. | New Drug Submission (NDS) · Admin |
| October 29, 2024 | RIVA-OXYBUTYNIN | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| October 29, 2024 | BUDESONIDE | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Admin |
| October 29, 2024 | AG-FINASTERIDE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 28, 2024 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | LUMAKRAS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | PMS-NAPROXEN | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | LORBRENA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | AMVUTTRA | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | DUAVIVE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2024 | IDARUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2024 | OCTAGAM; OCTAGAM 5% | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2024 | IPG-PREGABALIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2024 | DEFITELIO | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2024 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2024 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2024 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2024 | ADVIL FLU | Haleon Canada ULC | New Drug Submission (NDS) · Labelling Only |
| October 25, 2024 | SUGAMMADEX INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2024 | JAMP PREGABALIN CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2024 | ODAN-VALPROIC ACID | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2024 | TARO-PREGABALIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2024 | FIRAZYR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2024 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2024 | IMVEXXY | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2024 | REYATAZ | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2024 | TEVA-DILTIAZEM T | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 23, 2024 | TAMSULOSIN CR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 23, 2024 | NRA-FLUOXETINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2024 | MYLAN-LAMOTRIGINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 22, 2024 | DOMPERIDONE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| October 22, 2024 | FOLOTYN | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | CALQUENCE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | M-CITALOPRAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 22, 2024 | NAROPIN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | FIRDAPSE | Kye Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | EUGIA-HYDROXYUREA | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | LIVMARLI | Mirum Pharmaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | SANDOZ BILASTINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | GLN-BILASTINE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | JAMP BILASTINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | AURO-BILASTINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | MAR-BILASTINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2024 | SANDOZ BILASTINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 22, 2024 | M-BILASTINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2024 | NRA-BILASTINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2024 | PENTHROX | Endo Operations Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2024 | ALOG-DOXYLAMINE/PYRIDOXINE | Analog Pharma Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| October 21, 2024 | ALPROLIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2024 | EUTHYROX | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2024 | PMSC-ESOMEPRAZOLE DR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 21, 2024 | RETEVMO | Loxo Oncology Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2024 | ARAVA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2024 | MAR-SILDENAFIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 21, 2024 | JAMP LINEZOLID | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2024 | PIPERACILLIN/TAZOBACTAM POWDER FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2024 | MAR-FLUOXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 18, 2024 | AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2024 | EXTRA STRENGTH IBUPROFEN; IBUPROFEN CAPLETS; IBUPROFEN TABLETS | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2024 | MUSCLE & JOINT | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2024 | ACH-PREGABALIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2024 | MINT-RIVAROXABAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2024 | DIARRHEA RELIEF | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2024 | RIVA-BACLOFEN | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| October 18, 2024 | LEVOFLOXACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 17, 2024 | CEREZYME | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | LINEZOLID INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 17, 2024 | LOLO | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | M-FLUOXETINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 17, 2024 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | COZAAR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | APO-AMOXICILLIN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | ZORYVE | Arcutis Canada, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2024 | PRO-QUETIAPINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| October 17, 2024 | LINEZOLID INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 16, 2024 | SOGROYA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2024 | FOCLIVIA | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2024 | DIVIGEL | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2024 | TEVA-HALOPERIDOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2024 | APO-DESVENLAFAXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2024 | JAMP-PREGABALIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2024 | EVRYSDI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Priority |
| October 16, 2024 | NRA-TELMISARTAN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 16, 2024 | NRA-TELMISARTAN/HCTZ | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 15, 2024 | MED-DORZOLAMIDE-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | APO-LINEZOLID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | MED-CLINDAMYCIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | ALLERGY RELIEF LIQUID GELS | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | PRO-FLUOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 15, 2024 | LIDOCAINE HYDROCHLORIDE INJECTION | Laboratoire Aguettant | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | VIBERZI | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2024 | M-PRAVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 15, 2024 | AVIANE 21; AVIANE 28 | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2024 | ANASTROZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 15, 2024 | ACH-RIVAROXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2024 | XCOPRI | Endo Operations Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | VARIVAX III | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | DAYBUE | Acadia Pharmaceuticals Inc | New Drug Submission (NDS) · Priority-NAS |
| October 11, 2024 | APO-LAMOTRIGINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2024 | BESPONSA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | DIARRHEA RELIEF LIQUID GELS | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2024 | PRO-DAPAGLIFLOZIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 11, 2024 | AG-SITAGLIPTIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 11, 2024 | ELOCTATE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | TEVA-AFATINIB | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2024 | PMS-BICALUTAMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2024 | REACTINE 20 MG TABLET | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | SANDOZ AFATINIB | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2024 | OPZELURA | Incyte Corporation | New Drug Submission (NDS) · Other |
| October 11, 2024 | TYENNE | Fresenius Kabi Canada Ltd | New Drug Submission (NDS) · Other |
| October 11, 2024 | RYALTRIS | Glenmark Specialty Sa | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | ZEVTERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | FLUOXETINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| October 11, 2024 | NAROPIN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2024 | MAR-AFATINIB | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2024 | TARO-ATENOLOL | Sun Pharma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| October 11, 2024 | JIVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2024 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2024 | PREMARIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2024 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2024 | TEVA-BUPROPION XL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2024 | SYNJARDY | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | MENQUADFI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 9, 2024 | FLUOXETINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | DELSTRIGO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | DEPO-MEDROL; DEPO-MEDROL (WITH PRESERVATIVE) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | TEVA-ELETRIPTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 9, 2024 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2024 | KETOROLAC TROMETHAMINE INJECTION USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 9, 2024 | APO-KETOROLAC INJECTABLE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | MYLAN-INDAPAMIDE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | MESALAMINE | Tillotts Pharma Gmbh | New Drug Submission (NDS) · Admin |
| October 8, 2024 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | METRONIDAZOLE INJECTION, USP | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | SYNTHROID | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2024 | PLERIXAFOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2024 | APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2024 | TEVA-DILTIAZEM CD | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 7, 2024 | TRI-JORDYNA 21; TRI-JORDYNA 28 | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2024 | TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2024 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2024 | TEZSPIRE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2024 | AURO-CLINDAMYCIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2024 | PRO-AMOXI CLAV | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2024 | JAMP FLUDROCORTISONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2024 | SUPEUDOL 20 | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2024 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2024 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2024 | METHOTREXATE INJECTION, USP | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2024 | PRZ-SITAGLIPTIN-METFORMIN | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2024 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2024 | NRA-CANDESARTAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2024 | ACT LEVOFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2024 | HERZUMA | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| October 3, 2024 | TEVA-CLARITHROMYCIN XL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2024 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2024 | ESTALIS 140/50 MCG; ESTALIS 250/50 MCG | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2024 | AURO-TOFACITINIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2024 | DULOXETINE | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2024 | RIXIMYO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2024 | ONCOTICE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2024 | PMS-LEVOFLOXACIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2024 | PROQUAD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2024 | APO-FINASTERIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 2, 2024 | TARO-DESVENLAFAXINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 2, 2024 | JAMP RIVASTIGMINE CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 2, 2024 | JAMP BISOPROLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2024 | SILDENAFIL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 2, 2024 | ATORVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 1, 2024 | PMS-PREGABALIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2024 | TARO-CARBAMAZEPINE; TARO-CARBAMAZEPINE CHEWABLE TABLETS; TARO-CARBAMAZEPINE TABLETS | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2024 | PAROXETINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 1, 2024 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 1, 2024 | MULTAQ | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2024 | MAR-ONDANSETRON ODT | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2024 | M-M-R II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2024 | FLUOXETINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 27, 2024 | FUROSEMIDE INJECTION USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2024 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2024 | IMOVANE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2024 | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 27, 2024 | PMS-PALBOCICLIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 27, 2024 | APO-PANTOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2024 | BACLOFEN-10; BACLOFEN-20 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| September 27, 2024 | PMS-ONDANSETRON | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2024 | ESTRADOT 100; ESTRADOT 25; ESTRADOT 37.5; ESTRADOT 50; ESTRADOT 75 | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2024 | FLUOROURACIL INJECTION | Biolyse Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2024 | VOLTAREN EMULGEL EXTRA STRENGTH; VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| September 26, 2024 | JAMP LAMOTRIGINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | BREYANZI | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | TEGSEDI | Akcea Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | DOMPERIDONE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 25, 2024 | XALATAN | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | ONDANSETRON ODT | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2024 | APO-TERIPARATIDE INJECTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | TEVA-DILTIAZEM XC | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | IPG-EZETIMIBE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | APO-ANASTROZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | TEVA-EZETIMIBE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2024 | ZENRELIA | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| September 24, 2024 | TRILEPTAL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2024 | LINEZOLID INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2024 | JAMP DESVENLAFAXINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2024 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2024 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 24, 2024 | MOUNJARO KWIKPEN | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2024 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2024 | JAMP-FLUOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2024 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2024 | CASGEVY | Vertex Pharmaceuticals (Canada) Incorporated | New Drug Submission (NDS) · Priority-NAS |
| September 23, 2024 | MINT-ONDANSETRON ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2024 | ADVAGRAF | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2024 | PROGRAF | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2024 | NRA-LEVETIRACETAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 23, 2024 | EZETIMIBE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 23, 2024 | DUTASTERIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 20, 2024 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | APO-ROSUVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | AURO-PREGABALIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | ILLUCCIX | Telix Pharmaceuticals (Us) Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | VENLAFAXINE XR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 20, 2024 | TARO-METFORMIN XR | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2024 | NAT-PREGABALIN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | TEVA-MODAFINIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | OFEV | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | PMS-FINASTERIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2024 | TARO-RAMIPRIL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 20, 2024 | EPURIS | Cipher Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2024 | MOMETASONE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 19, 2024 | APO-HYDROXYQUINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2024 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2024 | TARO-PHENYTOIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2024 | MAR-LEFLUNOMIDE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 19, 2024 | FOSAMAX | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2024 | APO-OXYCODONE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2024 | QUATERNA | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2024 | TEVA-DULOXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 19, 2024 | M-RIVAROXABAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 18, 2024 | VALSARTAN HCT | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 18, 2024 | APO-HYDROMORPHONE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2024 | NRA-DAPAGLIFLOZIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 18, 2024 | TEVA-ELTROMBOPAG | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 18, 2024 | M-METFORMIN XR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 18, 2024 | AYVAKYT | Blueprint Medicines Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 18, 2024 | M-FINASTERIDE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 18, 2024 | SYNOVEX PRIMER | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2024 | PERJETA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2024 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2024 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2024 | BENVYON | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2024 | HYDREA | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2024 | LINEZOLID INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 17, 2024 | APO-VILAZODONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2024 | TARO-PALBOCICLIB | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2024 | SPIKEVAX | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2024 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2024 | SANDOZ LINEZOLID | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2024 | LUTATHERA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2024 | MAR-DIENOGEST | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 16, 2024 | SANDOZ TOFACITINIB | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 13, 2024 | REBLOZYL | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | NOVOLIN GE 30/70; NOVOLIN GE NPH; NOVOLIN GE TORONTO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | WOMEN'S MINOXIDIL FOAM | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 13, 2024 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | TYSABRI | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | APO-TERBINAFINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2024 | TEVA-DOMPERIDONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2024 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2024 | ACH-EZETIMIBE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2024 | INFLUVAC TETRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | CIPRO ORAL SUSPENSION | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | TEVA-CARBAMAZEPINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | DUAL ACTION PAIN | Perrigo International, Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2024 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | FLUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | INDAYO | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2024 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2024 | DIARRHEA RELIEF LIQUID CAPSULES | Juno Otc Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2024 | PRO-LISINOPRIL - 10; PRO-LISINOPRIL - 20; PRO-LISINOPRIL - 5 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| September 12, 2024 | METHOTREXATE INJECTION BP | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2024 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | MOUNJARO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | TAMSULOSIN CR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2024 | PMS-ISMN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2024 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2024 | JAMP VANCOMYCIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2024 | BOTOX; BOTOX COSMETIC | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2024 | IMDELLTRA | Amgen Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 11, 2024 | FOSAVANCE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2024 | DUOKOPT | Laboratoires Théa | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | PMS-VANCOMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | TEVA-ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | AURO-BRIVARACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | APO-BRIVARACETAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2024 | FRUZAQLA | Takeda Canada Incorporated | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 10, 2024 | METOJECT SUBCUTANEOUS | Medexus Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2024 | AURO-BRIVARACETAM | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 10, 2024 | APO-BRIVARACETAM | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 10, 2024 | CYTOSAR | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2024 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2024 | SANDOZ OSELTAMIVIR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 9, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2024 | RIVA-GABAPENTIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 9, 2024 | PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | Panacea Biotec Pharma Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2024 | AG-DORZOLAMIDE TIMOLOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 9, 2024 | APO-ATAZANAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2024 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2024 | AURO-ONDANSETRON ODT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2024 | SANDOZ DESVENLAFAXINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2024 | FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2024 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2024 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| September 6, 2024 | OCTREOTIDE ACETATE OMEGA | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2024 | FINASTERIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 6, 2024 | PLERIXAFOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | ACH-ROSUVASTATIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | IPG-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | NUVAXOVID XBB.1.5 | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2024 | JAMP ROSUVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2024 | CONSTELLA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2024 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2024 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10; HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50; HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | SPECTRO ECZEMACARE MEDICATED CREAM | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| September 5, 2024 | TEVA-LAMOTRIGINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | ACT EXEMESTANE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | TEVA-TAMSULOSIN CR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | AG-BISOPROLOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 5, 2024 | TAMSULOSIN CR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 5, 2024 | APO-SILDENAFIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | AURO-FLUOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2024 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2024 | INFLECTRA | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| September 4, 2024 | MIEBO | Bausch & Lomb Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 4, 2024 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2024 | TEVA-SILDENAFIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 4, 2024 | MEN'S MINOXIDIL FOAM | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 4, 2024 | LISINOPRIL | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| September 4, 2024 | M-PROGESTERONE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 4, 2024 | TEVA-TOBRAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 4, 2024 | EUGIA-LENALIDOMIDE | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 3, 2024 | MINT-ALENDRONATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2024 | DESMOPRESSIN SPRAY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2024 | VITRAKVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 3, 2024 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 3, 2024 | TARO-PRAVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 3, 2024 | RIVA-IRBESARTAN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 3, 2024 | MEFENAMIC | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 2, 2024 | PEMETREXED DISODIUM FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2024 | MED-DORZOLAMIDE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2024 | JAMP SITAGLIPTIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2024 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2024 | GONAL-F; GONAL-F PEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2024 | APO-BILASTINE ORAL SOLUTION; APO-BILASTINE ORODISPERSIBLE TABLETS; APO-BILASTINE TABLETS | Apotex Inc. | New Drug Submission (NDS) · Admin |
| August 30, 2024 | DANTROLENE SODIUM FOR INJECTION, USP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2024 | PRECEDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2024 | AG-LEVOCARB | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2024 | PREVNAR 20 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2024 | SIMVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2024 | IPG-SILDENAFIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2024 | AMB-BUSPIRONE | Ambicare Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2024 | VETORYL 20 MG | Dechra Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2024 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2024 | TECVAYLI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2024 | MYLAN-EFAVIRENZ | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2024 | APO-FLUCONAZOLE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| August 29, 2024 | FERINJECT | Vifor (International) Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2024 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2024 | TARO-ROSUVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2024 | WINREVAIR | Merck Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| August 28, 2024 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2024 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2024 | MABCAMPATH | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2024 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2024 | MED-ROSUVASTATIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2024 | PRZ-SITAGLIPTIN | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2024 | LORAZEPAM INJECTION, USP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2024 | TECVAYLI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2024 | ZEPOSIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2024 | SPRAVATO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2024 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2024 | APO-LEVOCARB | Apotex Inc. | New Drug Submission (NDS) · Admin |
| August 27, 2024 | AUDRINA 21; AUDRINA 28 | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2024 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2024 | VORANIGO | Servier Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| August 27, 2024 | MS CONTIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2024 | SANDOZ FINASTERIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2024 | RIVA-ESCITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 26, 2024 | SOLMECTIN INJECTION FOR CATTLE AND SWINE | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 26, 2024 | TEVA-NABILONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2024 | NEXAVAR | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2024 | APO-AMOXICILLIN-CLAVULANATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | TEVA-PROPOFOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | MAR-DILTIAZEM CD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | TEVA-GLICLAZIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | M-ESZOPICLONE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 23, 2024 | AMOXICILLIN/CLAV | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2024 | DANTRIUM INTRAVENOUS | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| August 23, 2024 | ADVIL MINI-GELS | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| August 23, 2024 | NRA-OLMESARTAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2024 | INTRAROSA | Cosette Pharmaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2024 | PYLERA | Laboratoires Juvise Pharmaceuticals | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2024 | SILDENAFIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2024 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2024 | TRUXIMA | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| August 22, 2024 | AG-AMOXI CLAV SUSPENSION | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 22, 2024 | DOPTELET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2024 | OLANZAPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 22, 2024 | CLOROTEKAL | B. Braun Melsungen Ag | New Drug Submission (NDS) · Other |
| August 22, 2024 | GLN-EZETIMIBE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 22, 2024 | TARO-CANDESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 22, 2024 | JAMP DIVALPROEX | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 22, 2024 | PRZ-TRAMADOL/ACET | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 21, 2024 | SPIKEVAX XBB.1.5 | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2024 | ACCRUFER | Kye Pharmaceuticals Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 21, 2024 | M-PANTOPRAZOLE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2024 | TRINIPATCH 0.2; TRINIPATCH 0.4; TRINIPATCH 0.6 | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| August 21, 2024 | PRO-BUSPIRONE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2024 | IBUPROFEN ORAL SUSPENSION, 100 MG / 5 ML | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 21, 2024 | MENQUADFI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2024 | UVADEX | Therakos Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2024 | JORVEZA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| August 20, 2024 | ADHEROZA | Accord Healthcare Inc | New Drug Submission (NDS) · Other |
| August 20, 2024 | ONCASPAR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2024 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2024 | PADCEV | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| August 20, 2024 | IXIFI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2024 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2024 | PRO-MIRTAZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 20, 2024 | XIIDRA | Bausch & Lomb Inc. | New Drug Submission (NDS) · Admin |
| August 20, 2024 | MONUROL | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| August 20, 2024 | IPG-FLUOXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2024 | LEQVIO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2024 | LUMAKRAS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2024 | APO-PRAMIPEXOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2024 | TARO-EZETIMIBE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 19, 2024 | APO-TIOTROPIUM | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2024 | CARBAGLU | Recordati Rare Diseases | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2024 | ARMLUPEG | Lupin Pharma Canada Limited | New Drug Submission (NDS) · Other |
| August 16, 2024 | PROPOFOL INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2024 | NEXVIAZYME | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2024 | TEVA-RIZATRIPTAN ODT | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2024 | PLENVU | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Other |
| August 16, 2024 | ZESTORETIC | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2024 | VERMOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2024 | ARESTIN MICROSPHERES | Ora Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2024 | PMS-VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 14, 2024 | STELARA; STELARA I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2024 | ATOMOXETINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 14, 2024 | CABTREO | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Other |
| August 14, 2024 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2024 | TRAVATAN Z | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2024 | CITALOPRAM - 10; CITALOPRAM - 20; CITALOPRAM - 40 | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| August 14, 2024 | APO-DAPAGLIFLOZIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2024 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2024 | BEYFORTUS | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2024 | RISEDRONATE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 13, 2024 | VENLAFAXINE XR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 13, 2024 | PRAMIPEXOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 13, 2024 | AURO-EZETIMIBE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2024 | PMS-BUSPIRONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2024 | AG-TICAGRELOR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2024 | TEVA-EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2024 | APO-LEVOTHYROXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2024 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2024 | PRZ-PROPRANOLOL | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2024 | NRA-ESCITALOPRAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2024 | DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2024 | ONDISSOLVE ODF | Takeda Canada Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2024 | AURO-PRAMIPEXOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2024 | AG-ESCITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2024 | LEDAGA | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2024 | AG-AMOXI CLAV | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2024 | AG-ESCITALOPRAM TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2024 | SANDOZ-CARBAMAZEPINE CR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2024 | TEVA-FROVATRIPTAN | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| August 9, 2024 | M-PIRFENIDONE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 9, 2024 | SOLNIXON | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 9, 2024 | LOPERACAP | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2024 | TORADOL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2024 | COMIRNATY OMICRON XBB.1.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2024 | ETOMIDATE INJECTION USP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2024 | ELOCOM | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2024 | KETAMINE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2024 | SANDOZ EZETIMIBE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2024 | LEMTRADA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2024 | PMS-DICLOFENAC-MISOPROSTOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2024 | TOBRAMYCIN INHALATION SOLUTION USP | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2024 | AURO-LAMOTRIGINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2024 | PYZCHIVA; PYZCHIVA IV | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| August 7, 2024 | PYZCHIVA; PYZCHIVA IV | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| August 7, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2024 | SENSORCAINE | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2024 | MAVENCLAD | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2024 | LAYLAA 21; LAYLAA 28 | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 6, 2024 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2024 | MAR-METFORMIN XR | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | TEVA-SUGAMMADEX INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | PMS-SUGAMMADEX | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2024 | SUGAMMADEX INJECTION | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 2, 2024 | LEVOTHYROXINE SODIUM FOR INJECTION | Avir Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2024 | APO-DAPAGLIFLOZIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2024 | KETOROLAC TROMETHAMINE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2024 | TEVA-FLUOXETINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2024 | KINEVAC | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2024 | MEZERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2024 | MYALEPTA | Chiesi Farmaceutici S.P.A. | New Drug Submission (NDS) · Admin |
| August 2, 2024 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2024 | ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 1, 2024 | MAR-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 1, 2024 | DIARRHEA RELIEF FAST DISSOLVE | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | SANDOZ ALENDRONATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | AA-ATENIDONE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | MYLAN-FLUCONAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | NAPROXEN LIQUID GELS | Juno Otc Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2024 | APO-LISINOPRIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 1, 2024 | SANDOZ DONEPEZIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | TEVA-LISINOPRIL (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2024 | DANTRIUM CAPSULES | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| July 31, 2024 | SPEVIGO | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2024 | FML | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2024 | TECVAYLI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2024 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2024 | LEVETIRACETAM INJECTION USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 31, 2024 | RIVA-OMEPRAZOLE DR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 31, 2024 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2024 | PMSC-RAMIPRIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 31, 2024 | JAMP-GABAPENTIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2024 | OXALIPLATIN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2024 | TRACLEER | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2024 | PROPOFOL INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2024 | SPRAVATO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2024 | AG-HYDROXYCHLOROQUINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2024 | STEQEYMA; STEQEYMA I.V. | Celltrion Inc. | New Drug Submission (NDS) · Other |
| July 30, 2024 | ARIDOL | Pharmaxis Europe Limited | New Drug Submission (NDS) · Admin |
| July 30, 2024 | SYLVANT | Recordati Rare Diseases Canada Inc | New Drug Submission (NDS) · Admin |
| July 30, 2024 | TARO-DULOXETINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2024 | APO-AMOXI | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2024 | SERTRALINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2024 | TABRECTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2024 | APO-ACYCLOVIR OINTMENT | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2024 | MINT-ROSUVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2024 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2024 | INQOVI | Taiho Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| July 26, 2024 | PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2024 | AURO-SILDENAFIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2024 | OMVYENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 25, 2024 | VENLAFAXINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2024 | JAMP-ATORVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2024 | BIO-AMLODIPINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2024 | REMERON RD | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2024 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2024 | MODAFINIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 24, 2024 | AMOXICILLIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | SOLIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2024 | APO-LITHIUM CARBONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | MINT-SILDENAFIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | VEPESID | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2024 | ACT PRAMIPEXOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | SANDOZ TAMSULOSIN CR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | TARO-SILDENAFIL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 24, 2024 | VABYSMO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2024 | AG-PANTOPRAZOLE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2024 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2024 | XYDALBA | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2024 | FLONASE ALLERGY RELIEF | Haleon Canada ULC | New Drug Submission (NDS) · Other |
| July 24, 2024 | XYWAV | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2024 | INFLECTRA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2024 | IDACIO | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2024 | ALKERAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2024 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2024 | ARIPIPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 22, 2024 | NAT-OMEPRAZOLE DR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 22, 2024 | DURATOCIN | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2024 | AG-GABAPENTIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2024 | CLINIMIX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | CARVYKTI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | VOYDEYA | Alexion Pharma Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 19, 2024 | VEREGEN | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| July 19, 2024 | OMEPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 19, 2024 | OMEPRAZOLE-20 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 19, 2024 | BORTEZOMIB INJECTION | Dr Reddys Laboratories Ltd | New Drug Submission (NDS) · Other |
| July 19, 2024 | APO-TAMSULOSIN CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2024 | NRA-GABAPENTIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2024 | PADCEV | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | CLINIMIX E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | CLINIMIX E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2024 | TIBSOVO | Servier Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 19, 2024 | NAPROXEN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2024 | PEPCID COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2024 | TENORMIN | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2024 | REVESTIVE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2024 | PEMETREXED FOR INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2024 | OMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 18, 2024 | MAR-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2024 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2024 | JAMP BISOPROLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2024 | PMS-EZETIMIBE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2024 | AURO-LIOTHYRONINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 17, 2024 | NRA-PREGABALIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2024 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2024 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2024 | SULCRATE; SULCRATE SUSPENSION PLUS | AbbVie Corporation | New Drug Submission (NDS) · Labelling Only |
| July 17, 2024 | NUCYNTA IR | Endo Operations Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2024 | M-LETROZOLE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 17, 2024 | SANDOZ DORZOLAMIDE/TIMOLOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2024 | TEVA-DAPAGLIFLOZIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 16, 2024 | PREVNAR 13 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2024 | AMLODIPINE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| July 16, 2024 | GALANTAMINE ER | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 16, 2024 | ATORVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 16, 2024 | SIMPARICA TRIO | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2024 | SIMPARICA | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2024 | CAPVAXIVE | Merck Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| July 15, 2024 | PMS-BACLOFEN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2024 | CETIRIZINE; CETIRIZINE EXTRA STRENGTH | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2024 | APO-TRAZODONE; APO-TRAZODONE D | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2024 | MINT-MEXILETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2024 | NRA-ALENDRONATE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2024 | NAT-QUETIAPINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2024 | ROCURONIUM BROMIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2024 | AURO-DAPAGLIFLOZIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2024 | JAMP DEFERASIROX (TYPE J) | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 15, 2024 | ASPIRIN 81MG; ASPIRIN 81MG QUICK CHEWS; ASPIRIN EXTRA STRENGTH; ASPIRIN REGULAR STRENGTH | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2024 | ACH-FLUOXETINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2024 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2024 | JAMP CABERGOLINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2024 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2024 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| July 12, 2024 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2024 | DORZOLAMIDE-TIMOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2024 | FEIBA NF | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2024 | FOSAPREPITANT FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| July 11, 2024 | ELOCTATE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2024 | RIXIMYO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2024 | ATACAND | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Labelling Only |
| July 11, 2024 | ATACAND PLUS | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Labelling Only |
| July 11, 2024 | ZILBRYSQ | Ucb Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 11, 2024 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2024 | TESTIM 1% | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| July 11, 2024 | SOFRACORT | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Admin |
| July 11, 2024 | DIPROSONE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2024 | PMSC-SIMVASTATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2024 | JAMP OLANZAPINE FC; JAMP OLANZAPINE ODT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 11, 2024 | KETOROLAC TROMETHAMINE INJECTION, USP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2024 | AG-SUMATRIPTAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 10, 2024 | PMS-LEVODOPA-CARBIDOPA | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 10, 2024 | TEVA-PIROXICAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2024 | XYREM | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2024 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 10, 2024 | MOUNJARO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2024 | TEVA-PRAZOSIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2024 | JAMP-FINASTERIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2024 | MAR-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 9, 2024 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2024 | AURO-ROSUVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2024 | QINLOCK | Deciphera Pharmaceuticals. Llc | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2024 | QUADRACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2024 | PENTACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2024 | CELESTONE SOLUSPAN | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2024 | MINT-FINASTERIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2024 | RIVA-ZOPICLONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 8, 2024 | NRA-LURASIDONE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2024 | ZADITOR | Laboratoires Théa | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2024 | ALEMBIC-LURASIDONE | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2024 | MINT-FLUOXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2024 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2024 | NRA-CITALOPRAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 5, 2024 | SANDOZ PRAMIPEXOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | SILDENAFIL TABLETS | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | TEVA-ALENDRONATE/CHOLECALCIFEROL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | SANDOZ ARIPIPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | ALLERGY RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | ALEVE CAPLETS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2024 | REYATAZ | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2024 | TRULICITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2024 | WINDEX MULTI-SURFACE DISINFECTANT SANITIZER CLEANER | S.C. Johnson and Son Limited | New Drug Submission (NDS) · Other |
| July 5, 2024 | JAMP ATENOLOL TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2024 | M-TRANEXAMIC ACID | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2024 | M-FEBUXOSTAT | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2024 | NRA-RIZATRIPTAN ODT | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 5, 2024 | NRA-ZOLMITRIPTAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2024 | APO-ALLOPURINOL TABLETS | Apotex Inc. | New Drug Submission (NDS) · Admin |
| July 5, 2024 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2024 | INREBIC | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2024 | RIVA ALENDRONATE; RIVA-ALENDRONATE FC | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2024 | IRBESARTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2024 | NAT-ESCITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 4, 2024 | MINT-LEVOCARB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2024 | SANDOZ PREGABALIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2024 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2024 | MED-DORZOLAMIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2024 | MAR-ESZOPICLONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 3, 2024 | BIO-RIVAROXABAN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| July 3, 2024 | BRIDION | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2024 | RIVA-LETROZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 3, 2024 | ADDYI | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2024 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2024 | IMOVAX RABIES | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2024 | MINT-PREGABALIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 2, 2024 | CEFTIOFUR SODIUM FOR INJECTION | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 2, 2024 | MEROPENEM FOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 28, 2024 | ACH-HYDROXYCHLOROQUINE SULFATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2024 | CLAVULIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | ARGATROBAN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | JAMP AMOXI CLAV | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2024 | AURO-AMOXICILLIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2024 | ENTOCORT | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | JAMP ZOPICLONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2024 | MAR-PIRFENIDONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2024 | REMSIMA; REMSIMA SC | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| June 28, 2024 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Priority |
| June 28, 2024 | RYBREVANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| June 28, 2024 | REZUROCK | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | XIIDRA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2024 | RIVA-SERTRALINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2024 | RIVA-FINASTERIDE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2024 | RIVA-FINASTERIDE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2024 | FUCITHALMIC | Amdipharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2024 | AYBINTIO | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2024 | VENLAFAXINE XR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 27, 2024 | FERINJECT | Vifor (International) Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2024 | ACH-FINASTERIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2024 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Priority |
| June 27, 2024 | ODAN-VALPROIC ACID | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2024 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | MINT-TOPIRAMATE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2024 | FAMOTIDINE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| June 26, 2024 | DIARRHEA RELIEF | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 26, 2024 | VAXNEUVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2024 | JAMP MODAFINIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | M-TICAGRELOR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | TEVA-EVEROLIMUS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | TEVA-MORPHINE SR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | GERMSTOPSQ | Envision Sq Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2024 | SURFACE CLEANER SANITIZER RTU; SMARTPOWER SINK & SURFACE CLEANER SANITIZER | Ecolab Co. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2024 | PURE HARD SURFACE | Pure Bioscience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2024 | PROVOCHOLINE; PROVOCHOLINE INHALATION SOLUTION | Methapharm Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2024 | SANDOZ REPAGLINIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2024 | AG-OMEPRAZOLE DR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 25, 2024 | VIBERZI | AbbVie Corporation | New Drug Submission (NDS) · Labelling Only |
| June 25, 2024 | CISPLATIN INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 25, 2024 | PIFELTRO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2024 | PRO-ZOPICLONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 25, 2024 | ACH-PROGESTERONE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 25, 2024 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2024 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2024 | GADOVIST 1.0 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2024 | INTELLI-DESVENLAFAXINE | Intellipharmaceutics Corp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2024 | APO-CETIRIZINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2024 | EBGLYSS | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 24, 2024 | AURO-QUINAPRIL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 21, 2024 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2024 | YUFLYMA | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| June 21, 2024 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2024 | CISATRACURIUM OMEGA MULTIDOSE | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2024 | SACUBITRIL-VALSARTAN | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| June 21, 2024 | AURO-FINASTERIDE 1 MG | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2024 | SUNOSI | Axsome Malta Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2024 | AG-LISDEXAMFETAMINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2024 | VENLAFAXINE XR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2024 | M-MONTELUKAST | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2024 | RETEVMO | Loxo Oncology Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2024 | MINT-FINASTERIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2024 | PUREGON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2024 | AG-LISDEXAMFETAMINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2024 | AG-LISDEXAMFETAMINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2024 | JAMP AMOXI CLAV SUSPENSION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2024 | IXCHIQ | Valneva Austria Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 20, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2024 | VIACORAM | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2024 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 20, 2024 | LEVETIRACETAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 20, 2024 | AA-MEDROXY | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2024 | M-RIZATRIPTAN ODT | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 19, 2024 | JAMP AMOXI CLAV SUSPENSION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2024 | JAMP TICAGRELOR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2024 | ADVIL PLUS ACETAMINOPHEN | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| June 19, 2024 | RIVA-LOPERAMIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2024 | FLUCONAZOLE-150 | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2024 | WAINUA | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 18, 2024 | TECARTUS | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2024 | RIVA-AZITHROMYCIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 18, 2024 | APIXABAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 18, 2024 | IBUPROFEN CAPLETS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 18, 2024 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2024 | MINT-ACARBOSE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 18, 2024 | AG-ALENDRONATE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 18, 2024 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2024 | OMVYENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 17, 2024 | ADCETRIS | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2024 | TECARTUS | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2024 | TARO-PEMETREXED | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 17, 2024 | AURO-LISINOPRIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2024 | PMS-OXYCODONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2024 | MAGNEVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2024 | PRIMOVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2024 | BEYFORTUS | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2024 | MEFENAMIC ACID | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| June 14, 2024 | GABAPENTIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2024 | PRZ-METOCLOPRAMIDE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2024 | PRZ-NEBIVOLOL | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2024 | FAMOTIDINE (ACID CONTROLLER) TABLETS | Teva Canada Limited | New Drug Submission (NDS) · Other |
| June 13, 2024 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2024 | MYSTEP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 13, 2024 | MITOMYCIN FOR INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2024 | PMS-AMIODARONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2024 | CLOTRIMAZOLE VAGINAL 3 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2024 | SAPHNELO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2024 | AG-AMOXICILLIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 13, 2024 | LURASIDONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2024 | TARO-DASATINIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | APO-AMOXI | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | LACOSAMIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2024 | MINT-AMOXI/CLAV | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | M-AMOXI CLAV | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | AURO-PIRFENIDONE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | AURO-AMOXICLAV | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2024 | APO-OMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 11, 2024 | HYQVIA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2024 | CATHFLO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2024 | LIBTAYO | Regeneron Canada Company | New Drug Submission (NDS) · Labelling Only |
| June 11, 2024 | EZETIMIBE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 11, 2024 | GADOVIST 1.0 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2024 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2024 | PMS-DAPAGLIFLOZIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 11, 2024 | SITAGLIPTIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 10, 2024 | BREYANZI | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2024 | ZIEXTENZO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2024 | PANENZA | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2024 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2024 | ACT CITALOPRAM | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| June 10, 2024 | CTP 30 | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| June 10, 2024 | NRA-MONTELUKAST | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 10, 2024 | SANDOZ PIRFENIDONE CAPSULES; SANDOZ PIRFENIDONE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2024 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2024 | KETOROLAC TROMETHAMINE INJECTION USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2024 | LEFLUNOMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 7, 2024 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 6, 2024 | PRO-LISDEXAMFETAMINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 6, 2024 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2024 | SANDOZ ESCITALOPRAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2024 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2024 | LEDERLE LEUCOVORIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2024 | ADYNOVATE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2024 | ANTIZOL | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| June 6, 2024 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2024 | JAMP ATORVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2024 | TEVA-SPIRONOLACTONE/HCTZ | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2024 | FLUDARABINE PHOSPHATE FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2024 | PRO-LISDEXAMFETAMINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| June 6, 2024 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2024 | NASAL ALLERGY AND CONGESTION RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2024 | JAMP RIVASTIGMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 5, 2024 | EYEZIRGAN | Laboratoires Théa | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2024 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2024 | SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2024 | CEFTIN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2024 | MYLAN-GALANTAMINE ER | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2024 | JAMP DOMPERIDONE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2024 | RIVA APIXABAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2024 | FROVA | Endo Operations Ltd. | New Drug Submission (NDS) · Admin |
| June 4, 2024 | APO-OXCARBAZEPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2024 | AZITHROMYCIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2024 | TEVA-ACEBUTOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2024 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2024 | IRBESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | PMS-PIRFENIDONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | DESVENLAFAXINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 3, 2024 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2024 | MAR-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 3, 2024 | WINDEX MULTI-SURFACE ANTIBACTERIAL DISINFECTANT 2 | S.C. Johnson and Son Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | APO-LISDEXAMFETAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 3, 2024 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2024 | ELURA | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| May 31, 2024 | PMS-GABAPENTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2024 | ALBRIOZA | Amylyx Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2024 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2024 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2024 | SANDOZ TAMSULOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2024 | CEFAZOLIN FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2024 | FLUOROURACIL INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2024 | APO-DIMETHYL FUMARATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2024 | LEVODOPA-CARBIDOPA | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| May 30, 2024 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2024 | NRA-CETIRIZINE TABLETS | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 30, 2024 | M-METFORMIN | Mantra Pharma Inc. | New Drug Submission (NDS) · Admin |
| May 30, 2024 | GAVRETO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2024 | TARO-LISINOPRIL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 30, 2024 | SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM | Seaford Pharmaceuticals Inc. | New Drug Submission (NDS) · Other |
| May 30, 2024 | DAYVIGO | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | JAMP GABAPENTIN CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | GABAPENTIN CAPSULES USP; GABAPENTIN TABLETS USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | IPG-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | AG-IRBESARTAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 29, 2024 | TEVA-NITROFURANTOIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | DEXEDRINE; DEXEDRINE SPANSULE | Paladin Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | TUKYSA | Seagen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2024 | EUGIA-BROMFENAC | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 29, 2024 | PMS-OXYBUTYNIN | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2024 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2024 | GREENWORKS DISINFECTING BATHROOM CLEANER | The Clorox Company of Canada Ltd. | New Drug Submission (NDS) · Admin |
| May 28, 2024 | JAMP FLUCONAZOLE 150 MG | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 28, 2024 | IVOZFO | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2024 | NALOXONE HYDROCHLORIDE INJECTION USP | Sterinova Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 28, 2024 | AZITHROMYCIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2024 | INREBIC | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2024 | ORILISSA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2024 | ALLERGY RELIEF LIQUID GELS | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2024 | CEREZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| May 28, 2024 | SANDOZ OLANZAPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2024 | JAMP LEUCOVORIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 27, 2024 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2024 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2024 | VERKAZIA | Apotex Inc. | New Drug Submission (NDS) · Admin |
| May 27, 2024 | NRA-PANTOPRAZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 27, 2024 | CLOTRIMAZOLE TOPICAL | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2024 | AG-TOPIRAMATE TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 27, 2024 | REDDY-PREGABALIN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 27, 2024 | JAMP TRAVOPROST Z | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 27, 2024 | EUGIA-SUNITINIB | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 27, 2024 | NRA-PAROXETINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 27, 2024 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2024 | APO-PERINDOPRIL/AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2024 | SANDOZ LISINOPRIL HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2024 | PMS-CLOPIDOGREL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| May 24, 2024 | PRZ-ROSUVASTATIN | Pharmaris Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2024 | BICILLIN L-A | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2024 | ESCITALOPRAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2024 | AG-DUTASTERIDE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2024 | NIFEDIPINE ER | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2024 | GLN-DAPAGLIFLOZIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2024 | RIVASTIGMINE | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| May 24, 2024 | NRA-ROSUVASTATIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2024 | DULOXETINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2024 | M-METFORMIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2024 | PRO-AMOXI CLAV | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 24, 2024 | FLUDARABINE PHOSPHATE FOR INJECTION; FLUDARABINE PHOSPHATE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2024 | OMNITROPE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2024 | TARO-OXALIPLATIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2024 | ORILISSA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2024 | APO-TAMSULOSIN CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2024 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2024 | APO-AZATHIOPRINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2024 | ACT VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2024 | VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2024 | RIVAROXABAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2024 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2024 | ACH-OMEPRAZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2024 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2024 | AG-GLICLAZIDE MR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 22, 2024 | GD-DICLOFENAC/MISOPROSTOL 50; GD-DICLOFENAC/MISOPROSTOL 75 | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 22, 2024 | MINT-VENLAFAXINE XR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2024 | JAMP ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2024 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | SANDOZ ARIPIPRAZOLE TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| May 21, 2024 | SANDOZ ARIPIPRAZOLE TABLET | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 21, 2024 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | SANDOZ ARIPIPRAZOLE TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | LIORESAL INTRATHECAL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2024 | TARO-ESCITALOPRAM | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2024 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2024 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | MAVENCLAD | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | ICATIBANT INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 17, 2024 | JAMTEKI | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | FERTILINE | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | IPG-CETIRIZINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2024 | GARDASIL9 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | MYOZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| May 17, 2024 | SIMULECT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | SANDOZ ESOMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2024 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 17, 2024 | ENVARSUS PA | Endo Operations Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2024 | APO-LATANOPROST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | GLN-GABAPENTIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | AG-AMOXICILLIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2024 | PRO-AMOX-250; PRO-AMOX-500 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2024 | SANDOZ ALFACALCIDOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2024 | CLINDAMYCIN INJECTION IN 5% DEXTROSE | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | TEVA-MODAFINIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2024 | KETOROLAC TROMETHAMINE INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | TEVA-LOSARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | TEVA-KETOCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | ARIXTRA | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2024 | MYLAN-VALACYCLOVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | M-RIZATRIPTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2024 | IBUPROFEN 200 MG; IBUPROFEN 400 MG | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2024 | DANTRIUM INTRAVENOUS | Endo Par Innovation Company, Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2024 | JAMP DIENOGEST | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | EPIDIOLEX | Jazz Pharmaceuticals Research Uk Limited | New Drug Submission (NDS) · Admin |
| May 16, 2024 | PMS-CHLORHEXIDINE; PMS-CHLORHEXIDINE WITHOUT ALCOHOL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2024 | PANTOPRAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2024 | ZOCOR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2024 | SIMVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 15, 2024 | PALYNZIQ | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2024 | ERELZI | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2024 | XCOPRI | Endo Operations Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2024 | DESVENLAFAXINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2024 | CABLIVI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2024 | PURINETHOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2024 | CYCLOPHOSPHAMIDE FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 14, 2024 | PHARMA-SIMVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2024 | AG-ATENOLOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2024 | IMJUDO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2024 | JAMP-ATENOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2024 | GEMCITABINE INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2024 | GAVRETO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2024 | PMS-PERINDOPRIL-AMLODIPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2024 | SANDOZ AMOXICILLIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2024 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2024 | APRETUDE | Viiv Healthcare Ulc | New Drug Submission (NDS) · Priority |
| May 10, 2024 | APO-GABAPENTIN; APO-GABAPENTIN TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2024 | FLUZONE | Sanofi Pasteur Limited | New Drug Submission (NDS) · Admin |
| May 10, 2024 | AURO-DAPAGLIFLOZIN / METFORMIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2024 | AURO-VENLAFAXINE XR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2024 | CITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2024 | APO-GLICLAZIDE MR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2024 | RIVASTIGMINE PATCH 10; RIVASTIGMINE PATCH 15; RIVASTIGMINE PATCH 5 | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2024 | VERZENIO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2024 | PMS-LITHIUM CARBONATE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2024 | MAR-RIVAROXABAN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 9, 2024 | HEARTBURN CONTROL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2024 | APO-GABAPENTIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2024 | APO-VORICONAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2024 | MINT-ITRACONAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2024 | EUGIA-NINTEDANIB | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2024 | IPG-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2024 | COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2024 | CISPLATIN INJECTION BP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2024 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2024 | EUGIA-GEFITINIB | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 7, 2024 | AG-AZITHROMYCIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 7, 2024 | AG-CITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 7, 2024 | JUBLIA | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2024 | METFORMIN TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2024 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2024 | PMS-ALENDRONATE-FC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2024 | M-AZITHROMYCIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 6, 2024 | ZOLADEX LA | Tersera Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2024 | MINT-GABAPENTIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2024 | SUPEUDOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2024 | ATENOLOL | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 3, 2024 | MICRO +4 REGULAR STRENGTH | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2024 | TARO-ATORVASTATIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2024 | SANDOZ FINASTERIDE A | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2024 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2024 | TEVA-RIVAROXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2024 | MULTI-12 INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2024 | TEVA-SAPROPTERIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 3, 2024 | JAMP QUINAPRIL/HCTZ | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 2, 2024 | EVISTA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2024 | CISPLATIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2024 | AG-ATENOLOL | Angita Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 2, 2024 | JAMP-ATENOLOL | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Admin |
| May 2, 2024 | AMIODARONE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 2, 2024 | APO-METHYLPHENIDATE ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2024 | QULIPTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2024 | JAMP POMALIDOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | TEVA-DASATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | CANCIDAS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2024 | BORTEZOMIB FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2024 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2024 | TARO-METHYLPREDNISOLONE INJECTION | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | LUPIN-TIOTROPIUM | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | TARO-IRBESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2024 | TEVA-ENTACAPONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2024 | NRA-LETROZOLE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2024 | JAMP-AZITHROMYCIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 30, 2024 | SANDOZ OMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 30, 2024 | TALVEY | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 30, 2024 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2024 | ESOMEPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 30, 2024 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 30, 2024 | JAMP ALLOPURINOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 29, 2024 | AG-TADALAFIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2024 | AG-TOPIRAMATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2024 | AG-ROSUVASTATIN CALCIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2024 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2024 | TEVA-SITAGLIPTIN MALATE / METFORMIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2024 | RYTHMOL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2024 | MINT-METFORMIN XR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2024 | TARO-CARBAMAZEPINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2024 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2024 | SANDOZ FESOTERODINE FUMARATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2024 | TEVA-BUPRENORPHINE/NALOXONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2024 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2024 | ALDURAZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 26, 2024 | RIVA-ALENDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2024 | CITALOPRAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2024 | PANTOPRAZOLE | 10445517 Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 26, 2024 | OPSYNVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2024 | CISPLATIN INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2024 | MICRO ZN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2024 | LUVOX | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2024 | CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM; CANESTEN SOFT CAPSULE 1 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2024 | SIMVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2024 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 25, 2024 | CELLCEPT | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2024 | MICAFUNGIN SODIUM FOR INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2024 | LOSARTAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 25, 2024 | ZOMIG; ZOMIG NASAL SPRAY; ZOMIG RAPIMELT | Xediton Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2024 | AG-ALENDRONATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2024 | JAMP-ALENDRONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 25, 2024 | PERINDOPRIL ERBUMINE/INDAPAMIDE; PERINDOPRIL ERBUMINE/INDAPAMIDE HD; PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| April 25, 2024 | TAMSULOSIN CR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 24, 2024 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2024 | SAXENDA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2024 | JAMP-TOPIRAMATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 23, 2024 | ASPEN-DIENOGEST | Aspen Pharmacare Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2024 | JAMP CEFUROXIME | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2024 | EPKINLY | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2024 | BIVALIRUDIN FOR INJECTION | Formative Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2024 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2024 | PMSC-CELECOXIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2024 | SANDOZ METFORMIN FC | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2024 | ESPEROCT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2024 | BIO-ATORVASTATIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 23, 2024 | APO-TELMISARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2024 | PREGABALIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 23, 2024 | ACT ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2024 | JAMP APREMILAST | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2024 | ALENDRONATE-10; ALENDRONATE-40; ALENDRONATE-5; ALENDRONATE-70 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 22, 2024 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2024 | JAMP ATAZANAVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2024 | TEVA-VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2024 | ACH-FESOTERODINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2024 | LEMTRADA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 19, 2024 | MABCAMPATH | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 19, 2024 | DIARRHEA RELIEF FAST DISSOLVE | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2024 | ACYCLOVIR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2024 | CIPROFLOXACIN | 10445517 Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 19, 2024 | M-MIDODRINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 19, 2024 | DIPENTUM | Atnahs Pharma Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2024 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2024 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2024 | MAR-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 18, 2024 | DALACIN C | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2024 | SILIQ | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2024 | MICRO MN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2024 | LUNESTA | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| April 18, 2024 | MYLAN-ATAZANAVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2024 | M-ALENDRONATE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 17, 2024 | NIOPEG | Nora Pharma Inc. | New Drug Submission (NDS) · Other |
| April 17, 2024 | APO-ABACAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2024 | FLUCONAZOLE TABLETS | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| April 17, 2024 | AUBAGIO | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 17, 2024 | REGIOCIT | Vantive Ulc | New Drug Submission (NDS) · Admin |
| April 17, 2024 | SANDOZ DORZOLAMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2024 | CALCITONIN SALMON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2024 | CERDELGA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 17, 2024 | TEVA-NARATRIPTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2024 | SIMVASTATIN-10; SIMVASTATIN-20; SIMVASTATIN-40; SIMVASTATIN-5; SIMVASTATIN-80 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 16, 2024 | FLOCTAFENINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 16, 2024 | PONSTAN | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2024 | APO-PREGABALIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2024 | VABYSMO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2024 | AG-DESVENLAFAXINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 15, 2024 | RBX-ATORVASTATIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 15, 2024 | TEVA-SILDENAFIL R | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2024 | IPG-GABAPENTIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2024 | TEVA-DEXTROAMPHETAMINE SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2024 | EXTRANEAL | Vantive Ulc | New Drug Submission (NDS) · Admin |
| April 12, 2024 | APO-ESCITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2024 | NRA-ROSUVASTATIN TABLETS | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 12, 2024 | TARO-GLICLAZIDE MR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2024 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | VEGZELMA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | TEVA-AZATHIOPRINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2024 | THYROGEN | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 11, 2024 | APO-IRBESARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2024 | CARBOPROST TROMETHAMINE INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 11, 2024 | PMS-METHYLPHENIDATE CR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2024 | MICRO I | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | MICRO CU | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | MICRO SE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | MICRO CR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2024 | TEVA-ESOMEPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2024 | TEVA-ALENDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2024 | AURO-ESCITALOPRAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2024 | NEURONTIN | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2024 | MIDAZOLAM INJECTION USP | Sterinova Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2024 | APO-MODAFINIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2024 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2024 | MINT-VARENICLINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 10, 2024 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2024 | XULTOPHY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2024 | ALBRIOZA | Amylyx Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2024 | FABRAZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 8, 2024 | TEVA-FUROSEMIDE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2024 | MYLAN-RIVASTIGMINE PATCH 10; MYLAN-RIVASTIGMINE PATCH 5 | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2024 | JAMP ALENDRONATE/VITAMIN D3 | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2024 | PMS-CHOLESTYRAMINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 8, 2024 | APO-RIVASTIGMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | PMSC-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | BYOOVIZ | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | NIX DERMAL CREAM | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| April 5, 2024 | LOPERAMIDE-2 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 5, 2024 | VOLTAREN EMULGEL EXTRA STRENGTH; VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | TEVA-DESVENLAFAXINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | PMS-NIFEDIPINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | CAPRELSA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 5, 2024 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | NORLUTATE | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | CETIRIZINE HYDROCHLORIDE CAPSULES | Catalent Ontario Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | NAT-CETIRIZINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | NRA-APIXABAN TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 5, 2024 | PENTHROX | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | VELTASSA | Vifor Fresenius Medical Care Renal Pharma Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | PRZ-AMLODIPINE | Pharmaris Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2024 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2024 | NAPROXEN LIQUID GELS | Juno Otc Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2024 | AURO-ALENDRONATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2024 | MINT-GLICLAZIDE MR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2024 | TARO-LATANOPROST | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2024 | RAPAMUNE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2024 | PONVORY | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2024 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2024 | SEPTRA INJECTION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2024 | TEVA-TIAPROFENIC ACID | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2024 | JAMP ALENDRONATE SODIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2024 | ACH-QUETIAPINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 3, 2024 | SANDOZ RIOCIGUAT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2024 | SANDOZ RIOCIGUAT | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 2, 2024 | NRA-QUETIAPINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 2, 2024 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2024 | RENAGEL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2024 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2024 | TEVA-ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2024 | AURO-RIVASTIGMINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2024 | PMS-ZOPICLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2024 | CAELYX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2024 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2024 | INNOHEP | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2024 | IBUPROFEN LIQUID GEL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 28, 2024 | JAMP-AMOXICILLIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2024 | CYCLOPHOSPHAMIDE FOR INJECTION USP | Andone Pharmaceutical Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 28, 2024 | PMS-PREDNISOLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2024 | INTELENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2024 | CARIPUL | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2024 | VEGZELMA | Celltrion Inc. | New Drug Submission (NDS) · Admin |
| March 28, 2024 | ZOLMITRIPTAN; ZOLMITRIPTAN ODT | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 28, 2024 | RIVA-CITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 28, 2024 | FOSRENOL | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2024 | AURO-CITALOPRAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2024 | CLOTRIMAZOLE VAGINAL 6 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2024 | RUKOBIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | APO-ALENDRONATE/VITAMIN D3 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2024 | METHOFILL SELF-DOSE INJECTOR | Accord Healthcare Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | GLICLAZIDE MR | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | JAMP FLUOXETINE SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 27, 2024 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2024 | APO-CLOMIPRAMINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2024 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2024 | FLOLAN; PH 12 STERILE DILUENT FOR FLOLAN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2024 | REBLOZYL | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| March 26, 2024 | NORDIMET | Nordic Group B.V. | New Drug Submission (NDS) · Other |
| March 26, 2024 | MAR-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 26, 2024 | PRO-RISPERIDONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 26, 2024 | KETAMINE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2024 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2024 | APO-RABEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2024 | WAYMADE-NAPROXEN SODIUM; WAYMADE-NAPROXEN SODIUM DS | Waymade Plc | Supplement to a New Drug Submission (SNDS) · Admin |
| March 26, 2024 | NATCO-CITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2024 | TARO-CIPROFLOXACIN/DEXAMETHASONE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2024 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2024 | IPG-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2024 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2024 | NRA-ATORVASTATIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 22, 2024 | XPOVIO | Forus Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2024 | SANDOZ RIVASTIGMINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2024 | XYNTHA; XYNTHA SOLOFUSE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2024 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2024 | TOUJEO SOLOSTAR/TOUJEO DOUBLESTAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2024 | APO-CARVEDILOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2024 | CARBOPLATIN INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 22, 2024 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2024 | PNEUMOVAX 23 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2024 | OKEDI | Laboratorios Farmaceuticos Rovi, S.A. | New Drug Submission (NDS) · Other |
| March 21, 2024 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2024 | PANTOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2024 | CYSVIEW | Photocure Asa | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2024 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 20, 2024 | TEVA-LATANOPROST | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 20, 2024 | MIRAPEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2024 | VYVANSE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2024 | MYLAN-CILAZAPRIL | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 20, 2024 | CITALOPRAM-20; CITALOPRAM-40 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2024 | CLAVASEPTIN 250 MG; CLAVASEPTIN 50 MG; CLAVASEPTIN 500 MG; CLAVASEPTIN 62.5 MG; CLAVASEPTIN 750 MG | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2024 | APOQUEL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2024 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2024 | EUGIA-PROGESTERONE | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 19, 2024 | EUGIA-METHOTREXATE | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 19, 2024 | NRA-OLANZAPINE ODT | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 19, 2024 | MYLAN-RILUZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 19, 2024 | APO-CABERGOLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 19, 2024 | TARO-PERAMPANEL | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 19, 2024 | SANDOZ ESTRADIOL DERM 100; SANDOZ ESTRADIOL DERM 50; SANDOZ ESTRADIOL DERM 75 | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 19, 2024 | ATARAX | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2024 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2024 | M-DILTIAZEM T | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 16, 2024 | APO-LATANOPROST-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | MINT-ESCITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | PMS-ALENDRONATE; PMS-ALENDRONATE-FC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | APO-TOFACITINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | DEPO-MEDROL; DEPO-MEDROL (WITH PRESERVATIVE) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | JAMP LEVOCARB | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2024 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | MINIPRESS | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | TEVA-SPIRONOLACTONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | CEFAZOLIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | APO-VALSARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | CARBOPLATIN INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | TARO-METHYLPHENIDATE ER | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | ACH-ESCITALOPRAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2024 | JAMP-AMOXICILLIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2024 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | BEYFORTUS | Sanofi Pasteur Limited | New Drug Submission (NDS) · Admin |
| March 14, 2024 | PHESGO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2024 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2024 | TEVA-SULINDAC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | JAMP MYCOPHENOLIC ACID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 14, 2024 | APO-TRIMEBUTINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 14, 2024 | ACUVAIL | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | MYLAN-DIVALPROEX | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | CALDOLOR | Cumberland Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | DEPO-MEDROL WITH LIDOCAINE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2024 | SOLU-MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | TEVA-ATENOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | BIO-PANTOPRAZOLE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| March 13, 2024 | PREVYMIS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | NORDITROPIN FLEXPRO; NORDITROPIN NORDIFLEX | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | TECENTRIQ; TECENTRIQ SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | KESIMPTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2024 | APO-DOXYCYCLINE MODIFIED RELEASE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2024 | SANDOZ DOXYCYCLINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 13, 2024 | APO-DOXYCYCLINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 12, 2024 | AWIQLI | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 12, 2024 | NUCEIVA | Evolus Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2024 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2024 | APO-OFLOXACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2024 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2024 | TEVA-PIROXICAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2024 | MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2024 | SPIKEVAX XBB.1.5 | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2024 | MAR-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2024 | AURO-FAMOTIDINE 10 MG; AURO-FAMOTIDINE 20 MG | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 11, 2024 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2024 | YUFLYMA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2024 | FERINJECT | Vifor (International) Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 11, 2024 | M-DILTIAZEM CD | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 11, 2024 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2024 | JAMP DUTASTERIDE CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 11, 2024 | ACH-TOPIRAMATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2024 | TYPHIM VI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2024 | TECHNELITE | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2024 | HYOSCINE BUTYLBROMIDE INJECTION BP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2024 | MINT-PRAVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 8, 2024 | TARO-TADALAFIL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 8, 2024 | SUMATRIPTAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 8, 2024 | ABRAXANE FOR INJECTABLE SUSPENSION | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| March 8, 2024 | AG-RIVAROXABAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2024 | MYLAN-GLICLAZIDE MR | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2024 | APO-SIMVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2024 | DESLORATADINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2024 | ACT METHYLPHENIDATE ER | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2024 | TEVA-COMBO STERINEBS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2024 | LAMICTAL | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2024 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2024 | TEVA-FOSINOPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2024 | MINT-LETROZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2024 | BREYANZI | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| March 6, 2024 | RUXIENCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2024 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2024 | AG-RIVAROXABAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 6, 2024 | TEVA-EVEROLIMUS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2024 | VRAYLAR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2024 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2024 | ESTROGEL | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2024 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2024 | PANHEMATIN | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2024 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2024 | SPINRAZA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2024 | APO-QUINAPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 5, 2024 | MED-RIVASTIGMINE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2024 | AURO-RUFINAMIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 4, 2024 | TEPMETKO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2024 | LYRICA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2024 | AZITHROMYCIN | 10445517 Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2024 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2024 | ERIBULIN MESYLATE INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 2, 2024 | SANDOZ TIMOLOL | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 1, 2024 | TEVA-SIMVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 1, 2024 | SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 1, 2024 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2024 | PRZ-AMOXICILLIN | Pharmaris Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2024 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2024 | IBUPROFEN MINI LIQUID CAPSULES | Juno Otc Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 1, 2024 | THALOMID | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| March 1, 2024 | CITALOPRAM-10 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 1, 2024 | WYOST | Sandoz Canada Inc. | New Drug Submission (NDS) · Other |
| March 1, 2024 | M-ATORVASTATIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 1, 2024 | METHOTREXATE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2024 | IPG-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 29, 2024 | TEVA-CITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 29, 2024 | MINT-CITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 29, 2024 | ONUREG | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| February 29, 2024 | NAT-BENDAMUSTINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 29, 2024 | EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES; IBUPROFEN LIQUID CAPSULES | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 29, 2024 | TEVA-SALBUTAMOL HFA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 29, 2024 | CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 29, 2024 | AERIUS SINUS + ALLERGY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 29, 2024 | PMS-ESTRADIOL 10 | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 29, 2024 | ZOFRAN ODT | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 29, 2024 | ETHACRYNATE SODIUM | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 28, 2024 | RIVA-SITAGLIPTIN TARTRATE/METFORMIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 28, 2024 | PLUVICTO | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2024 | NETSPOT | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2024 | LOCAMETZ | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2024 | LUTATHERA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2024 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2024 | XENPOZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| February 27, 2024 | WILATE | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2024 | RIVA SITAGLIPTIN/METFORMIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 27, 2024 | TEVA-ERLOTINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2024 | RISPERIDONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 27, 2024 | PRO-NIFEDIPINE ER | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 27, 2024 | ISTODAX | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| February 27, 2024 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2024 | TEGRETOL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2024 | MED-VORICONAZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2024 | CORTOTIC | Virbac Ah, Inc. | New Drug Submission (NDS) · Other |
| February 26, 2024 | APO-ATENOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2024 | ATENOLOL | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 26, 2024 | PANTOPRAZOLE MAGNESIUM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 26, 2024 | OMEPRAZOLE-20 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 23, 2024 | MYLAN-ESCITALOPRAM | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | APO-ALENDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2024 | JUXTAPID | Chiesi Farmaceutici S.P.A. | New Drug Submission (NDS) · Admin |
| February 23, 2024 | TEVA-EFAVIRENZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | PRO-AMOX-125; PRO-AMOX-250 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 23, 2024 | MAR-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 23, 2024 | APO-CLINDAMYCIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | CLOPROSTENOL VEYX SW | Modern Veterinary Therapeutics Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2024 | CLOPROSTENOL VEYX | Modern Veterinary Therapeutics Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2024 | BRAFTOVI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2024 | NEXIUM 24HR | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2024 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2024 | LOCAMETZ | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2024 | NETSPOT | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2024 | NRA-OLANZAPINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2024 | BUPIVACAINE HEAVY INJECTION BP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 22, 2024 | JAMP SITAGLIPTIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2024 | SITAGLIPTIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 21, 2024 | JANUMET; JANUMET XR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2024 | JAMP GLICLAZIDE-MR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2024 | AG-CYCLOBENZAPRINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 21, 2024 | TARO-BUPRENORPHINE/NALOXONE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2024 | JAMP VORICONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2024 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2024 | MED-ROSUVASTATIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2024 | BUPIVACAINE INJECTION BP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 20, 2024 | NRA-TADALAFIL TABLETS | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 20, 2024 | APO-VALSARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2024 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2024 | HEPAGAM B | Ki Biopharma Llc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2024 | MIRENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2024 | MINT-SIMVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2024 | XOFIGO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2024 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2024 | APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2024 | ATORVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 19, 2024 | TEVA-ATENOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2024 | LEVETIRACETAM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2024 | JUBBONTI | Sandoz Canada Inc. | New Drug Submission (NDS) · Other |
| February 16, 2024 | TEVA-FLUVOXAMINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 16, 2024 | SEASONIQUE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2024 | CAMZYOS | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2024 | BUSPIRONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 16, 2024 | MOZOBIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2024 | APO-ROSUVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2024 | SEASONALE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2024 | NAPROXEN - 250; NAPROXEN - 375; NAPROXEN - 500 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2024 | AURO-TAMSULOSIN CR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2024 | VANCOCIN | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2024 | CARBOPLATIN INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2024 | APO-METHIMAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2024 | PMS-TOFACITINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2024 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2024 | REMSIMA SC | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2024 | TEVA-PAROXETINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2024 | JAMP IMATINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 15, 2024 | JAMP SUMATRIPTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2024 | ATENOLOL | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| February 14, 2024 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2024 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2024 | JAMP ABACAVIR / LAMIVUDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2024 | JAMP LAMIVUDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2024 | JAMP SUMATRIPTAN DF | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2024 | BAQSIMI | Amphastar Pharmaceuticals Inc | New Drug Submission (NDS) · Admin |
| February 13, 2024 | JAMP MISOPROSTOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 13, 2024 | VIDAZA | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| February 13, 2024 | LEDAGA | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | FERRLECIT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | HERCEPTIN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | ARTHROTEC 50; ARTHROTEC 75 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | CALQUENCE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | JAMP TRAMADOL HCL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2024 | VYXEOS | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | TEVA-ABACAVIR/LAMIVUDINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2024 | RIVA-RISPERIDONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 13, 2024 | ZYVOXAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2024 | RIVA-ATENOLOL | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 12, 2024 | KESIMPTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2024 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2024 | JAMP ROSUVASTATIN CALCIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2024 | FLUGLUCOSCAN | Alberta Health Services | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2024 | TRURAPI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2024 | FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 11, 2024 | PMS-CLOPIDOGREL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 9, 2024 | RIVA-FLUCONAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2024 | ACH-ALENDRONATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2024 | TEVA-TERIFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2024 | APO-OLOPATADINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2024 | JAMP IRBESARTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2024 | JAMP-RAMIPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2024 | APO-CANDESARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2024 | AG-RAMIPRIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2024 | REVLIMID | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| February 9, 2024 | EXTRA STRENGTH ALLERGY RELIEF | Juno Otc Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2024 | AMOXICILLIN CAPSULES BP | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2024 | XYLASED 100 | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| February 8, 2024 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2024 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2024 | RIVA-ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2024 | RUXIENCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2024 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2024 | JAMP DESVENLAFAXINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2024 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2024 | ONIVYDE | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2024 | LEFLUNOMIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2024 | AG-TICAGRELOR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2024 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2024 | BOTOX | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2024 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2024 | PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2024 | MICRO +6 CONCENTRATE; MICRO PLUS 6 PEDIATRIC | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2024 | APO-AZITHROMYCIN Z | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2024 | PMS-ZIPRASIDONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 6, 2024 | METOPROLOL-L | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 6, 2024 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2024 | JAMP ITRACONAZOLE ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2024 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2024 | MEZERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2024 | VALSARTAN HCT | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 5, 2024 | JAMP-FLUCONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 5, 2024 | JAMP LOPERAMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 4, 2024 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2024 | ACID CONTROLLER MAXIMUM STRENGTH | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2024 | AVAXIM | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2024 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2024 | NINLARO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2024 | JAMP NITROFURANTOIN BID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2024 | APO-LINEZOLID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2024 | EYLEA HD | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2024 | PMS-CITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2024 | TEVA-FLUOXETINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2024 | BRUKINSA | Beigene Switzerland Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2024 | COMBOGESIC IV | BioSyent Pharma Inc. | New Drug Submission (NDS) · Other |
| February 1, 2024 | PEGASYS | Pharmaand Gmbh | New Drug Submission (NDS) · Admin |
| February 1, 2024 | SELEXID | Karo Healthcare Ab | New Drug Submission (NDS) · Admin |
| February 1, 2024 | PUREGON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2024 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2024 | SUMATRIPTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 1, 2024 | NRA-BETAHISTINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 1, 2024 | SANDOZ DESVENLAFAXINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2024 | REVOLUTION PLUS | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2024 | AURO-TOFACITINIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2024 | VELSIPITY | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 31, 2024 | ALEVE NIGHTTIME | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2024 | DEPO-MEDROL; DEPO-MEDROL (WITH PRESERVATIVE) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2024 | BUPRIXA | Zoetis Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2024 | JAMP RIVAROXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2024 | JAMP RIVAROXABAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2024 | MELPHALAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2024 | JAMP RIVAROXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2024 | MAR-AZITHROMYCIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 30, 2024 | LANSOPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 30, 2024 | EUGIA-ONDANSETRON INJECTION; ONDANSETRON INJECTION BP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2024 | FML | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2024 | NUBAIN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2024 | LUPIN-TIOTROPIUM | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 26, 2024 | OLUMIANT | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2024 | REPLAGAL | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2024 | IMJUDO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2024 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2024 | ALFAXAN MULTIDOSE | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| January 26, 2024 | TRUQAP | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 26, 2024 | PROZAC | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2024 | SANDOZ MEMANTINE FCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2024 | RIVA-ANASTROZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2024 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2024 | WAKIX | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2024 | SERTRALINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 25, 2024 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2024 | JAMP CEFADROXIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 25, 2024 | TEVA-EFAVIRENZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2024 | TEVA-SITAGLIPTIN MALATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2024 | ACYCLOVIR SODIUM INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2024 | APO-DEXLANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2024 | APO-DEXLANSOPRAZOLE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 25, 2024 | APTIOM | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| January 25, 2024 | MODAFINIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 25, 2024 | POMALYST | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| January 24, 2024 | MYLAN-NIFEDIPINE EXTENDED RELEASE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2024 | LANSOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 24, 2024 | APO-PREGABALIN CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2024 | APO-DESVENLAFAXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2024 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2024 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 23, 2024 | BIMZELX | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2024 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2024 | KINEVAC | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2024 | PMS-LOPERAMIDE; PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2024 | REXULTI | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2024 | JAMP-GABAPENTIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 23, 2024 | CEFUROXIME FOR INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 22, 2024 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 22, 2024 | MINT-ROSUVASTATIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2024 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2024 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2024 | BACLOFEN | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| January 19, 2024 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2024 | SERTRALINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2024 | OXALIPLATIN INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2024 | MINT-PANTOPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2024 | LATUDA | Sumitomo Pharma Canada, Inc. | New Drug Submission (NDS) · Admin |
| January 19, 2024 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2024 | PMSC-NIFEDIPINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2024 | ALESSE 21; ALESSE 28 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2024 | EZETROL | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2024 | MINT-POSACONAZOLE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 18, 2024 | JAMP SULFASALAZINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 18, 2024 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2024 | ERTAPENEM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2024 | DILTIAZEM CD | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| January 18, 2024 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | OCTAPLEX | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | TEZSPIRE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | VYNDAQEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | MYALEPTA | Amryt Pharmaceuticals Dac | New Drug Submission (NDS) · Priority-NAS |
| January 17, 2024 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | LEVOTHYROXINE SODIUM FOR INJECTION; LEVOTHYROXINE SODIUM INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | AMOXICILLIN | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| January 17, 2024 | IDAMYCIN PFS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2024 | AURO-PANTOPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2024 | BUPIVACAINE INJECTION BP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2024 | ODAN ITRACONAZOLE | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 17, 2024 | TARO-VALSARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 17, 2024 | TEVA-AZITHROMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2024 | GAMMAGARD S/D | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2024 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2024 | APO-BRIMONIDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2024 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2024 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 15, 2024 | BUPIVACAINE HEAVY INJECTION BP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2024 | PMS-ATENOLOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| January 15, 2024 | M-CETIRIZINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 15, 2024 | VALSARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 15, 2024 | TEVA-ATOMOXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 14, 2024 | SULFATRIM; SULFATRIM DS TABLETS; SULFATRIM PEDIATRIC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2024 | MYLAN-ATAZANAVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2024 | JAMP AMOXI CLAV | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2024 | APO-TERIFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2024 | ZEULIDE DEPOT | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2024 | TEVA-VALSARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2024 | TEVA-EZETIMIBE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 12, 2024 | GRANISETRON HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 12, 2024 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2024 | TEVA-TRAMADOL/ACETAMINOPHEN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2024 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2024 | SOMAVERT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2024 | CELECOXIB | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 11, 2024 | M-LANSOPRAZOLE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 11, 2024 | OXALIPLATIN INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2024 | BORTEZOMIB FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2024 | JAMP BACLOFEN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2024 | ORGALUTRAN | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2024 | AZITHROMYCIN FOR INJECTION, USP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2024 | IPG-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2024 | CABAZITAXEL FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2024 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2024 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2024 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2024 | IRBESARTAN HCT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2024 | NRA-SITAGLIPTIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2024 | AG-SIMVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2024 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | AURO-SIMVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | AURO-ROSUVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | AURO-MODAFINIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | TARO-ROSUVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | TARO-SIMVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | M-TERIFLUNOMIDE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | APO-IRBESARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | DOCETAXEL INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | VAXCHORA | Bavarian Nordic As | New Drug Submission (NDS) · Admin |
| January 9, 2024 | IDELVION | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | TEVA-CANDESARTAN/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | APO-TOPIRAMATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | QUVIVIQ | Idorsia Pharmaceuticals Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | AURO-GABAPENTIN TABLETS | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2024 | UPH-TADALAFIL | Uphealth Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 9, 2024 | GIVLAARI | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2024 | ACH-TERIFLUNOMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2024 | RABAVERT | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2024 | VORICONAZOLE FOR INJECTION | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2024 | PANTOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 8, 2024 | ACCEL-LEFLUNOMIDE | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2024 | VALSARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 8, 2024 | MAR-ATORVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2024 | AURO-TELMISARTAN HCTZ | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2024 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| January 5, 2024 | TOPIRAMATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2024 | SIMPONI; SIMPONI I.V | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2024 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2024 | AURO-MIRTAZAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2024 | ACH-OSELTAMIVIR PHOSPHATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2024 | NORTRIPTYLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2024 | JAMP TOPIRAMATE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2024 | LIXIANA | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2024 | REACTINE COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2024 | AURO-RISEDRONATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2024 | OXALIPLATIN INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2024 | OXALIPLATIN INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2024 | SANDOZ BISOPROLOL TABLETS | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2024 | JAMP-PANTOPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2024 | RIVA-SERTRALINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2024 | AURO-GEFITINIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2024 | S.O.S. NALOXONE HYDROCHLORIDE INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2024 | MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP | B.Braun Medical Inc | New Drug Submission (NDS) · Other |
| January 3, 2024 | JAMP PANTOPRAZOLE SODIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2024 | AURO-VALSARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2024 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2024 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2024 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2024 | TEVA-TOFACITINIB | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 3, 2024 | MACROSYN | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2024 | VALSARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | VALSARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | TRANEXAMIC ACID INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | TEVA-NALOXONE NASAL SPRAY | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2024 | JAMP DUTASTERIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | IRBESARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | NRA-DUTASTERIDE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2024 | ALENDRONATE-10; ALENDRONATE-40; ALENDRONATE-5; ALENDRONATE-70 | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2024 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 2, 2024 | TEVA-NALOXONE NASAL SPRAY | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |